Silence Therapeutics launches $150 million ADS follow-on offering - SLN News | RalliesSilence Therapeutics launches $150 million ADS follow-on offering
S
SLN• Silence Therapeutics launches ADS follow-on offering
- Silence Therapeutics launched an underwritten public offering of about $150 million of American depositary shares in the U.S.
- Each ADS represents three ordinary shares; underwriters hold a 30-day option to buy up to 15% more ADSs.
- Jefferies, Morgan Stanley, Cantor, and William Blair were named joint book-running managers.
CMTG
•
